The purpose of this study is to determine the safety and efficacy of ONO-5046Na in patients with acute respiratory failure associated with community-acquired pneumonia
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
174
twenty four hour infusion at 0 mg/kg/hr for 14 days
twenty four hour intravenous infusion at 0.2 mg/kg/hr for 14 days
Chugoku Region
Chugoku, Japan
Chubu Region
Chūbu, Japan
Hokkaido Region
Hokkaido, Japan
Hokuriku Region
Hokuriku, Japan
pulmonary function
Time frame: 14 days
mortality
Time frame: 28 days
ventilator status
Time frame: 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Kanto Region
Kanto, Japan
Kinki Region
Kinki, Japan
Kyushu Region
Kyushu, Japan
Shikoku Region
Shikoku, Japan
Tohoku Region
Tohuku, Japan